A spin-off from the Institut d'Optique Graduate School, Université Paris-Saclay, UNVEIL is a deeptech start-up that aims at facilitating the development and production of biologics (drugs derived from living organisms, such as messenger RNA vaccines, as opposed to chemical ones). These biologics (gene therapy, RNA vaccines, etc.) are transported to the target site in the human body by nanometric vectors (viruses or lipid nanoparticles).
R&D and production of these biomedicines is hampered by the lack of effective technology to measure vector loading.
UNVEIL has developped an optical, label-free instrument capable of quickly and easily measuring nanovector loading in solution, as well as their size and concentration.
Want to know more: visit our website !
Company Details
- Employees
- 4
- Founded
- 2024
- Address
- Verrières Le Buisson, Fr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Verrières le Buisson
Unveil Questions
Unveil's website is http://www.unveil-instruments.com
Unveil's LinkedIn profile is https://fr.linkedin.com/company/unveil-instruments
Unveil has
4 employees.
View email and phone details for 4
employees at Unveil.
Unveil's industry is
Biotechnology Research
Unveil's top competitors are
Myriad4sensing,
Zebramed,
Hemodynes,
Papilio.bio,
Unveil®,
Mycelium Technologies,
E-Mirgency,
Advanced Care Technologies, Inc,
Luxoderm,
Infocus Therapeutics.
Unveil's categories are Biotechnology Research
Unveil's founding year is 2024
